Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers

NCT01553136 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01553136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
May 31, 2016
Enrollment
131 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcohol drinking, alcoholism, smoking